COMPOUND PROFILE / COMBINATIONS
GHRP-2 + CJC-1295.
Research draftThis entry combines GHRP-2 and a CJC-1295-labelled product.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Identity and evidence review notes
Confirm exact identity, sequence, alias or formulation before attaching product-specific evidence.
Component references are background only. No directly matched controlled combination result was established in this pass.
Overview
This entry combines GHRP-2 and a CJC-1295-labelled product.
Mechanism
It is proposed to combine ghrelin-receptor and GHRH signalling; DAC status changes exposure.
Human research
Human evidence for component hormone responses is not evidence of long-term benefit for the exact stack.
Preclinical & other research
GHRH-secretagogue experiments provide context, but different molecules cannot be substituted.
Safety & unknowns
Combined hormonal, glucose and exposure effects need clinical assessment.
Regulatory status
Resolve CJC sequence and DAC status before attaching evidence; no exact-stack authorisation was established.
Reported use & evidence
The supplied GHRP-2 + CJC-1295 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.